חזרה לתוצאות החיפוש

The STOP-MED CTRCD Trial

חו"ל (דורש נסיעה)מגייס משתתפיםPHASE4

מצבים רפואיים

Heart Failure · Cardiotoxicity · Cardiac Toxicity · Antineoplastics Toxicity · Cancer

סיכום בשפה פשוטהבעזרת בינה מלאכותית

הסיכום נכתב על־ידי מודל שפה והוא ניסיוני. המידע עלול להיות חלקי או שגוי ואינו תחליף לייעוץ רפואי.

מיקומים

  • University of California, Los Angeles, Los Angeles, California, United States

    Contact: Study coordinator (Eric Yang, MD) · EHYang@mednet.ucla.edu · 310-825-4321
    Contact: Principal Investigator (Eric Yang, MD)

  • Brigham and Women's Hospital, Boston, Massachusetts, United States

    Contact: Study coordinator (Tomas Neilan, MD) · TNEILAN@mgh.harvard.edu
    Contact: Principal Investigator (Tomas Neilan, MD)

  • Baker Heart and Diabetes Institute, Melbourne, Victoria, Australia

    Contact: Study coordinator (Tom Marwick, MD)
    Contact: Principal Investigator (Tom Marwick, MD)

  • Cardio-Oncology Clinic, MAHI, University of Alberta Hospital, Edmonton, Alberta, Canada

    Contact: Study coordinator (Gabor Gyenes, MD)
    Contact: Principal Investigator (Gabor Gyenes, MD)
    Edith Pituskin, PhD (Sub-investigator)

  • St. Boniface Hospital, Winnipeg, Manitoba, Canada

    Contact: Study coordinator (Davinder Jassal, MD)
    Contact: Principal Investigator (Davinder Jassal, MD)

  • Hamilton General Hospital, Hamilton, Ontario, Canada

    Contact: Study coordinator (Darryl Leong, MD)
    Contact: Principal Investigator (Darryl Leong, MD)

  • University of Ottawa Heart Institute, Ottawa, Ontario, Canada

    Contact: Study coordinator (Ian Paterson, MD)
    Contact: Principal Investigator (Ian Paterson, MD)

  • St Michael's Hospital, Toronto, Ontario, Canada

    Contact: Study coordinator (Kim Connelly, MD)
    Contact: Principal Investigator (Kim Connelly, MD)

  • University Health Network, Toronto, Ontario, Canada

    Contact: Study coordinator (Paaladinesh Thavendiranathan, MD) · dinesh.thavendiranathan@uhn.ca · 416-340-5326
    Contact: Principal Investigator (Paaladinesh Thavendiranathan, MD)

  • Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland

    Contact: Study coordinator (Anna Borowiec, MD) · Anna.Borowiec@nio.gov.pl · 48 22 546 20 00
    Contact: Principal Investigator (Anna Borowiec, MD)

  • La Paz University Hospital, Madrid, Spain

    Contact: Study coordinator (Teresa Lopez Fernandez, MD) · teresa.lopez@salud.madrid.org · +34 917 27 70 00
    Contact: Principal Investigator (Teresa Lopez Fernandez, MD)

  • Barts Health NHS Trust, University College London, London, London, United Kingdom

    Contact: Study coordinator (Charlotte Manisty, MD)
    Contact: Principal Investigator (Charlotte Manisty, MD)

  • Liverpool Heart and Chest Hospital, Liverpool, United Kingdom

    Contact: Study coordinator (Rebecca Dobson, MD) · Rebecca.Dobson@lhch.nhs.uk · 44 151 600 1616
    Contact: Principal Investigator (Rebecca Dobson, MD)

  • Guy's and St Thomas' NHS Foundation Trust (Royal Brompton Hospital), London, United Kingdom

    Contact: Study coordinator (Alexander Lyon, MD) · 44 20 7352 8121
    Contact: Principal Investigator (Alexander Lyon, MD)
    Siva Tharshini Ramalingam, MD (Sub-investigator)
צפייה במקור ב־ClinicalTrials.gov(נפתח בחלון חדש)